Your Passion, Our Protection
More than legal protection, we’re true partners to those shaping culture through creativity.
In a 23 page opinion, a panel of the United States Court of Appeals for the Tenth Circuit has reversed the Utah District Court and held that the FDA's ban on low dose ephedra was not arbitrary or capricious.
Next stop, Supreme Court?
Neutraceutical Corp. v. Von Eschenbach, No. 05-4151 (Aug. 17, 2006)
From general questions to potential IP misuse, choose the option that best fits your case.
Our team will review your submission and get back to you as soon as possible.